The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $508.25, ...

Vertex Pharmaceuticals will soon try to commercialize another medicine. The new therapy targets the same market as four of its other products. Using a priority review voucher is an expensive choice, ...

Vertex Pharmaceuticals (VRTX) is back in focus after Wolfe Research upgraded the stock to Outperform, citing increased confidence in its investigational IgA nephropathy therapy and plans to use a ...

Total revenues of $666.8 million for the full year 2024, representing a 16.5% year-over-year increase, indicating strong business growth. Cloud revenues grew by 28.6% year-over-year for the full year ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the 44th ...

Switzerland-based CRISPR Therapeutics (CRSP) and Boston, Massachusetts-based Vertex (VRTX) have been collaborating together since signing an initial agreement in 2015, with Vertex paying CRISPR $75m ...

Google Cloud began offering Vertex AI in 2021 to help developers, data scientists, and companies build and use generative AI models on one platform. Now, at Google Cloud Next, Google announced updates ...

Vertex Flooring introduces distinctive marquetry flooring crafted with expert precision, offering custom wood designs ...